| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |